GREAT POINT PARTNERS LLC Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$212.2B
Holdings
26
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (26 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ISIIONIS PHARMACEUTICALS INC | 505,007 | $17.7B | 8.32% | |
| 2 | CYTKCYTOKINETICS INC | 360,000 | $16.9B | 7.98% | |
| 3 | KALVKALVISTA PHARMACEUTICALS INC | 1,787,003 | $15.1B | 7.13% | |
| 4 | VRDNVIRIDIAN THERAPEUTICS INC | 750,000 | $14.4B | 6.78% | |
| 5 | PLRXPLIANT THERAPEUTICS INC | 1,055,000 | $13.9B | 6.55% | |
| 6 | ABVXABIVAX SA | 1,648,523 | $12.1B | 5.69% | |
| 7 | DVAXDYNAVAX TECHNOLOGIES CORP | 860,000 | $11.0B | 5.18% | |
| 8 | NGNENEUROGENE INC | 442,761 | $10.1B | 4.77% | |
| 9 | EOLSEVOLUS INC | 895,524 | $9.9B | 4.66% | |
| 10 | XENEXENON PHARMACEUTICALS INC | 245,272 | $9.6B | 4.53% | |
| 11 | UNCYUNICYCIVE THERAPEUTICS INC | 10,980,000 | $8.7B | 4.11% | |
| 12 | ZURAZURA BIO LTD | 3,170,194 | $7.9B | 3.73% | |
| 13 | AUTLAUTOLUS THERAPEUTICS PLC | 3,009,392 | $7.1B | 3.33% | |
| 14 | JSPRJASPER THERAPEUTICS INC | 322,380 | $6.9B | 3.25% | |
| 15 | MRUSMERUS N V | 158,092 | $6.6B | 3.13% | |
| 16 | DNTHDIANTHUS THERAPEUTICS INC | 275,000 | $6.0B | 2.83% | |
| 17 | HLXCHELIX ACQUISITION CORP II | 500,000 | $5.3B | 2.47% | |
| 18 | UPBUPSTREAM BIO INC | 300,000 | $4.9B | 2.32% | |
| 19 | CNTXCONTEXT THERAPEUTICS INC | 4,683,711 | $4.9B | 2.32% | |
| 20 | VYGRVOYAGER THERAPEUTICS INC | 826,751 | $4.7B | 2.21% | |
| 21 | ORKAORUKA THERAPEUTICS INC | 228,803 | $4.4B | 2.09% | |
| 22 | MREOMEREO BIOPHARMA GROUP PLC | 1,150,000 | $4.0B | 1.90% | |
| 23 | RZLTREZOLUTE INC | 621,894 | $3.0B | 1.44% | |
| 24 | PMNEURPROMIS NEUROSCIENCES INC | 2,645,128 | $2.5B | 1.18% | |
| 25 | 0OPOPTINOSE INC | 370,269 | $2.5B | 1.17% | |
| 26 | URGNUROGEN PHARMA LTD | 187,843 | $2.0B | 0.94% |